Replies to post #621364 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

This is from their own website just today:

DCVax® – L
Our lead product is DCVax-L for Glioblastoma multiforme (“GBM”), the most lethal form of primary brain cancer. We have completed two Phase I/II trials and are now well under way with a large Phase III trial, as described below.